-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Regenerx Biopharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
- Regenerx Biopharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2023 was -$385K, a 9.17% increase year-over-year.
- Regenerx Biopharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2023 was -$1.69M, a 2.83% decline year-over-year.
- Regenerx Biopharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$1.73M, a 8.12% decline from 2021.
- Regenerx Biopharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$1.6M, a 4.88% decline from 2020.
- Regenerx Biopharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2020 was -$1.52M, a 8.48% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)